Li Wen-Jie, Mo Rui-Yu, Li Xiao-Jiang
Department of Oncology, The First Affiliated Hospital of Tianjin University of Chinese Medicine, Tianjin 300381, China.
Tianjin Key Laboratory of TCM Prescription Transformation Research, Tianjin 300381, China.
Zhonghua Nan Ke Xue. 2020 Sep;26(9):832-837.
Metastasis is an adverse factor in the recovery of prostate cancer, and oligometastatic prostate cancer is a disease different from localized and widespread metastatic prostate cancer. The patients may benefit from local treatment in terms of quality of life and survival time. Concerning the existing methods for the diagnosis and treatment of oligometastatic metastatic prostate cancer, researchers have advanced various views, such as "further elaboration of methodology", "specificity in the choice of treatment", and "better consideration of both local and systemic treatments". This review outlines recent advances in the studies of oligometastatic prostate cancer, hoping to provide some ideas benefiting the treatment of the malignancy.
转移是前列腺癌康复过程中的一个不利因素，而寡转移前列腺癌是一种不同于局限性和广泛性转移前列腺癌的疾病。患者在生活质量和生存时间方面可能会从局部治疗中获益。关于现有的寡转移前列腺癌诊断和治疗方法，研究人员提出了各种观点，如“方法的进一步细化”、“治疗选择的特异性”以及“更好地兼顾局部和全身治疗”。本综述概述了寡转移前列腺癌研究的最新进展，希望能为这种恶性肿瘤的治疗提供一些有益的思路。
